Navigation Links
Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop
Date:9/25/2008

Presentations Include Proof-of-Concept Animal Data on Previously Disclosed Fusion Protein TT30 and New Molecules TT32 and mAb171

CAMBRIDGE, Mass., Sept. 25 /PRNewswire/ -- Taligen Therapeutics Inc. today announced that data from in vivo disease models on several of the company's pipeline candidates will be presented next week at the XXII International Complement Workshop in Basel, Switzerland.

The data, which will be presented in eight oral and poster presentations, are the results of research conducted by the laboratories of Michael Holers, M.D., chief scientific officer of Taligen, and the company's academic collaborators in the complement research community. Five studies testing the company's fusion protein TT30 and two new compounds, a fusion protein TT32 and a monoclonal antibody mAb171, in animal models are highlighted below. These data further support Taligen's approach that targeting the alternative complement pathway can impact complement-mediated inflammatory disease processes.

Poster Presentations:

TT30

Targeted inhibition of the alternative pathway by CR2-fH fusion protein ameliorates progression of renal disease in MRL/lpr mice

Hideharu Sekine*, Gary Gilkeson, Stephen Tomlinson

Oct. 1, 2008, Posters - 10:30 a.m. - noon, Session 2, Poster 174

Alternative complement pathway signaling in a mouse model of choroidal neovascularisation

Barbel Rohrer*, Qin Long, Brooks Wilson, Beth Coughlin, Yuxiang Huang, Fei Qiao, Peter Tang, Kannan Kunchithapautham, Gary Gilkeson, Stephen Tomlinson

Oct. 1, 2008, Posters - 10:30 a.m. - noon, Session 2, Poster 202

TT30 and TT32

Targeted complement-inhibitory proteins CR2-Crry and CR2-fH ameliorate allergen-induced airway hyperresponsiveness and inflammation

Joshua Thurman*, Katsuyuki Takeda, Stephen Tomlinson, Erwin Gelfand, V. Michael Holers

Oct. 1, 2008, Posters - 10:30 a.m. - noon, Session 2, Poster 171

The role
'/>"/>

SOURCE Taligen Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Baxter Initiates Phase III Trial for the Treatment of Alzheimers Disease
2. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
3. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
4. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
5. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
6. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
7. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
8. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
9. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
10. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
11. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... STAMFORD, Conn. , April 20, 2015 /PRNewswire/ ... announced that Alan Butcher has joined ... & Business Development. Alan will have responsibility for ... commercial, near-commercial, and development-stage products that would benefit ... bringing aboard a proven leader," said Purdue President ...
(Date:4/20/2015)... April 20, 2015  U.S. pharmacy cost increases for active ... into the low double-digits by 2016, according to an analysis ... health solutions business of Aon plc (NYSE: ... projected to be 9.5 percent in 2015 and will continue ... predicts a similar rate of increase in 2017, with ...
(Date:4/20/2015)... 2015 Cardinal Innovations Healthcare Solutions ... high-tech, high-touch service delivery, is featuring its highly ... the National Council for Behavioral Health,s annual National ... 20–22, 2015, at the Gaylord Palms Resort and ... , attracts participants from mental health and addiction ...
Breaking Medicine Technology:Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3
(Date:4/20/2015)... NY (PRWEB) April 21, 2015 ... a 2015 Professional Woman of the Year. Ms. Webb ... healthcare. As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... over 200 local chapters. , “We are like an ...
(Date:4/20/2015)... April 20, 2015 The NFL draft season ... of players to add to their rosters, both for their ... In this episode of SCI TV , Vinnie ... acquisition of Greg Hardy given increased attention on off-field conduct ... year after the Ray Rice scandal brought media scrutiny, once ...
(Date:4/20/2015)... At the famous Avalon Hollywood on April 8th, ... Lounge, with Choices Recovery as the premier sponsor. Organizer ... placement in TV and film, gathered some of the ... goods and services for this daylong event. , ... Celebrity Interview Lounge, speaking with many of the notable ...
(Date:4/20/2015)... Utah (PRWEB) April 20, 2015 Goodreads ... Employer-Provided Health Insurance: Why It’s Good for You and ... , Paul Zane Pilzer and Rick Lindquist have ... Health Insurance: Why It’s Good for You and Your ... nation’s employer health insurance woes - employer-funded individual health ...
(Date:4/20/2015)... Hilo, Hawaii (PRWEB) April 20, 2015 ... , so hurry and secure your space at the start ... 12, 2015, the Olympic-distance race is limited to 500 participants ... Kenoi has already secured his spot). , Now thru April ... $75 for relay team members; after May 1st, the fee ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Suzanne Webb, Chief Executive Officer at Exclusive Surgeries Network, LLC, a 2015 Professional Woman of the Year 2Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3
... PALM BEACH, Fla., Oct. 12 The inaugural Cosmetic ... was called an unqualified success by those that attended. ... the meeting was a great learning opportunity and it ... LLC and its corporate partners. Attendees came from ...
... Noninvasive Medical Technologies, Inc. (NMT), an award-winning company ... pleased to commit its support to the Tim Davis Special ... man teams are currently relay marching over 824 miles across ... plaque with Staff Sgt. Tim Davis, name engraved. U.S. ...
... stem cells are being used to help develop a heart ... researchers have achieved a first step toward growing a living ... mouse embryonic stem cells, Duke University bioengineers performed a series ... develop into heart muscle. , The researchers used a special ...
... ... Inc., innovative provider of one-stop, flat-fee healthcare information technology and support, ... records (EMR) clients through the hiring of new Chief Healthcare Officer ... hosting and billing services to practices and medical groups of all ...
... CHICAGO, Oct. 12 On Tuesday, October 13, in response ... 33 state think tanks will announce their "patient-centered" plan for ... a national study by public policy specialist Art Laffer, will ... on a conference call open to the press (dial-in information ...
... ... receives Active Substance Master File for Cell Sense in vivo imaging agent , ... Pittsburgh, PA (Vocus) October 12, 2009 -- ... for its lead in vivo imaging reagent, Cell Sense CS-1000 (Cell Sense). , ,Celsense filed a ...
Cached Medicine News:Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 2Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 3Health News:Lab Study Makes Strides in Mending Hearts 2Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 2Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 3Health News:The Obamacare Alternative: 33 State Think Tanks Announce Patient-Centered Health Care Reforms 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 3
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
Medicine Products: